OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).
OBM Neurobiology publishes research articles, technical reports and invited topical reviews. Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Archiving: full-text archived in CLOCKSS.
Publication Speed (median values for papers published in 2022): Submission to First Decision: 6 weeks; Submission to Acceptance: 14 weeks; Acceptance to Publication: 8 days (1-2 days of FREE language polishing included)
Gut Feelings: The Role of the Human Gut Microbiome in Neurological Health and Ill Health.
Submission Deadline: June 30, 2024 (Open) Submit Now
Dr. Lynne Ann Barker, BSc (hons) First Class, PhD, PG. Cert. Associate Professor of Cognitive Neuroscience
Centre for Behavioural Science and Applied Psychology, Department of Psychology, Sociology and Politics, Sheffield Hallam University, Sheffield, UK.
Research interests: brain injury; neuropsychological interventions; innovations in brain injury assessment and therapy; gut microbiome; cognition; executive functions; concussion; Parkinson’s disease.
Dr. Caroline Jordan, BSc, MSC, PhD
University of Derby, UK
Research interests: neurological disorders, microbiome, diet-disease processes, behaviour change.
About This Topic
The human gut contains around 100 trillion micro-organisms collectively known as the gut microbiome. The human genome consists of about 23000 genes, whereas the gut microbiome encodes over three million genes producing thousands of metabolites influencing the host’s fitness, phenotype, and health. Gut microbes communicate with the host through multiple pathways and systems including enteric, autoimmune, and endocrine systems. There exists a complex bidirectional mechanism, the Gut-Brain axis, between the gastrointestinal (GI) tract and the central nervous system (CNS). Animal and laboratory research have established the potent influence of gut microbial metabolites on neural function, but more data is needed in humans in health and in neurological conditions. This special edition intends to encapsulate this broad scope and invites manuscripts in these areas.
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.